Acta Med. 1999, 42: 13-14

https://doi.org/10.14712/18059694.2019.139

Soluble Interleukin 2 Receptors' Levels Versus Thyroid Hormones Levels in Nonthyroidal Disease

Ioannis Iliasa, Georgios Panoutsopoulosb, Nikiforos Filippouc, Anna Dimac, Ioulia Christakopouloub, Paraskevi Roussoud

aSotiria Hospital, Department of Medicine, Athens, Greece
bSotiria Hospital, Department of Nuclear Medicine, Athens, Greece
cSotiria Hospital, Ninth Department of Pulmonary Medicine, Athens, Greece
dThird Department of Medicine, University of Athens, Athens, Greece

Received October 1, 1998
Accepted April 1, 1999

References

1. Theze J, Alzari PM, Bertoglio J. Interleukin 2 and its receptors: recent advances and new immunological functions. Immunol Today 1996; 10:481-6. <https://doi.org/10.1016/0167-5699(96)10057-C>
2. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function and clinical application. Ann Intern Med 1990; 113:619-28. <https://doi.org/10.7326/0003-4819-113-8-619>
3. Chrobak L. Clinical significance of soluble interleukin-2 receptor. Acta Med (Hradec Kralove) 1996; 39:3-6.
4. Mariotti S, Caturegli G, Barbesino G et al. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL 2) receptor (sIL-2R) in thyroid diseases. Clin Endocrinol 1992; 37:415-22.
5. Smallridge RC, Tsokos GC, Burman KD et al. Soluble interleukin-2 receptor is a thyroid hormone-dependent early response marker in the treatment of thyrotoxicosis. Clin Diagn Lab Immunol 1997; 4:583-6.
6. Chow CC, Mak TW, Chan CH, Cockram CS. Euthyroid sick syndrome in pulmonary tuberculosis before and after treatment. Ann Clin Biochem 1995; 32:385-91. <https://doi.org/10.1177/000456329503200406>
7. Hill AR, Schmidt FJ, Schussler GC. Rapid changes in thyroid function tests upon treatment of tuberculosis. Tub Lung Dis 1995; 76:223-9. <https://doi.org/10.1016/S0962-8479(05)80009-7>
8. Ilias I, Tselebis A, Boufas A, Panoutsopoulos G, Filippou N, Christakopoulou J. Pulmonary tuberculosis and its therapy do not significantly affect thyroid function tests. Int J Clin Pract 1998; 52:227-8.
9. Takahashi S, Setoguchi Y, Nukiwa T, Kira S. Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis. Chest 1991; 99:310-4. <https://doi.org/10.1378/chest.99.2.310>
10. Loviselli A, Calia MA, Murenu S, Mossa P, Cambosu MA, Caradonna A. Circulating soluble IL-2 receptor levels are low in patients with hypothyroid autoimmune thyroiditis. Horm Metab Res 1994; 26:548-51. <https://doi.org/10.1055/s-2007-1001754>
11. Komorowski J, Jankiewicz J, Robak T, Blasinska-Morawiec M, Stepien H. Cytokines serum levels as the markers of thyroid activation in Graves' disease. Immunol Lett 1998; 60:143-8. <https://doi.org/10.1016/S0165-2478(97)00151-X>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive